Yale S. Arkel

733 total citations
35 papers, 473 citations indexed

About

Yale S. Arkel is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Yale S. Arkel has authored 35 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 14 papers in Cardiology and Cardiovascular Medicine and 9 papers in Genetics. Recurrent topics in Yale S. Arkel's work include Blood Coagulation and Thrombosis Mechanisms (15 papers), Platelet Disorders and Treatments (8 papers) and Pregnancy and preeclampsia studies (7 papers). Yale S. Arkel is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (15 papers), Platelet Disorders and Treatments (8 papers) and Pregnancy and preeclampsia studies (7 papers). Yale S. Arkel collaborates with scholars based in United States, Denmark and Italy. Yale S. Arkel's co-authors include Michael J. Paidas, Jacob I. Haft, M. Kamiyama, Charles J. Lockwood, Dotun Ogunyemi, Jens Langhoff‐Roos, Andrew Thurston, Mi‐Jeong Lee, Francisco Cuéllar and Joseph M. Sherwood and has published in prestigious journals such as Cancer, Kidney International and CHEST Journal.

In The Last Decade

Yale S. Arkel

34 papers receiving 443 citations

Peers

Countries citing papers authored by Yale S. Arkel

Since Specialization

Citations

This map shows the geographic impact of Yale S. Arkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yale S. Arkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yale S. Arkel more than expected).

Fields of papers citing papers by Yale S. Arkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yale S. Arkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yale S. Arkel. The network helps show where Yale S. Arkel may publish in the future.

Co-authorship network of co-authors of Yale S. Arkel

This figure shows the co-authorship network connecting the top 25 collaborators of Yale S. Arkel. A scholar is included among the top collaborators of Yale S. Arkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yale S. Arkel. Yale S. Arkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated first trimester maternal levels of soluble fibrin polymer are associated with lower birthweight in twin gestation 2006 ·Blood Coagulation & Fibrinolysis ·Gabriele Urban, (unknown), Yale S. Arkel, Andrei Rebarber, Charles J. Lockwood, Michael J. Paidas	1
2	Inherited Thrombophilias and Adverse Pregnancy Outcome: Screening and Management 2005 ·Seminars in Perinatology ·Michael J. Paidas, (unknown), Jens Langhoff‐Roos, Yale S. Arkel	39
3	Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications 2005 ·Journal of Thrombosis and Haemostasis ·Michael J. Paidas, (unknown), Mi‐Jeong Lee, (unknown), Andrew Thurston, Charles J. Lockwood, Yale S. Arkel	53
4	Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome 2004 ·Clinics in Perinatology ·Michael J. Paidas, (unknown), Yale S. Arkel	29
5	Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis 2003 ·Kidney International ·(unknown), Yale S. Arkel, (unknown), F. Lee Lucas, Jonathan Himmelfarb	2
6	Circulating levels of inflammatory cytokines (IL-1β and TNF-α), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies 2003 ·Thrombosis and Haemostasis ·Yale S. Arkel, (unknown), Charles J. Lockwood, (unknown)	25
7	The Association Between Inherited Thrombophilia, Antiphospholipid Antibodies and Lipoprotein A Levels with Obstetrical Complications in Pregnancy 2002 ·Journal of Thrombosis and Thrombolysis ·Dotun Ogunyemi, (unknown), Yale S. Arkel	20
8	The use of coagulation activation markers (soluble fibrin polymer, TpPTM, prothrombin fragment 1.2, thrombin–antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders 2002 ·Blood Coagulation & Fibrinolysis ·Yale S. Arkel, Michael J. Paidas, (unknown)	17
9	The use of thrombus precursor protein, D-dimer, prothrombin fragment 1.2, and thrombin antithrombin in the exclusion of proximal deep vein thrombosis and pulmonary embolism 2000 ·Blood Coagulation & Fibrinolysis ·(unknown), Yale S. Arkel, (unknown), Daniel Gibson, C. Raymond Lake, (unknown)	22
10	A Case Report of a Paroxysmal Nocturnal Hemoglobinuria with Increased Coagulation Activation Markers while on Treatment with LMWH with Anti-Xa Levels above the Therapeutic Range 2000 ·Thrombosis and Haemostasis ·(unknown), (unknown), (unknown), (unknown), Yale S. Arkel	1
11	Ischemic stroke in a young patient with protein C deficiency and prothrombin gene mutation G20210A 1998 ·Blood Coagulation & Fibrinolysis ·Yale S. Arkel, (unknown), (unknown), (unknown)	8
12	A Highly Specific Functional Test for Factor V Leiden: A Modified Tissue Factor Assay for Activated Protein C Resistance 1997 ·Pathophysiology of Haemostasis and Thrombosis ·Yale S. Arkel, (unknown), M. Kamiyama, (unknown), Hansjüerg Alder, Alexandre Marchand	6
13	Acquired yon Willebrand's syndrome in association with a lupus‐like anticoagulant corrected by intravenous immunoglobulin 1994 ·American Journal of Hematology ·(unknown), Yale S. Arkel, (unknown), M. Kamiyama	29
14	Effect of intravenous immunoglobulin on inhibition of fibrinogen binding to platelets by sera from patients with immune thrombocytopenia 1993 ·American Journal of Hematology ·M. Kamiyama, Yuichi Yoshimura, Karen Chen, Yale S. Arkel	1
15	Inhibition of human platelet glycoprotein IIB/IIIA binding to fibrinogen by tumor cell membrane proteins. 1993 ·PubMed ·M. Kamiyama, Karen Chen, Jean S. Lynch, Yale S. Arkel	4
16	Correlation of cross-linked fibrin degradation products (D-dimer) with coronary angiographic lesion morphology 1991 ·International Journal of Cardiology ·(unknown), Jacob I. Haft, (unknown), Jonathan Goldstein, Yale S. Arkel, (unknown)	1
17	Immune complexes in hemophilia 1981 ·American Journal of Hematology ·Thomas R. Poskitt, (unknown), (unknown), Yale S. Arkel	10
18	Hypercalcemic crisis associated with the hypereosinophilic syndrome 1978 ·The American Journal of Medicine ·(unknown), George Schneider, (unknown), Yale S. Arkel	3
19	Effect of Emotional Stress on Platelet Aggregation in Humans 1976 ·CHEST Journal ·Jacob I. Haft, Yale S. Arkel	39
20	Effect of Emotional Stress on Platelet Function in Humans 1975 ·Thrombosis and Haemostasis ·(unknown), Yale S. Arkel	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact